Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Burden of Manual Cell Counting Alleviated by New Cell Counter Instrument

By LabMedica International staff writers
Posted on 24 Sep 2015
The burden of manual cell counting for biotech, biopharm, and other life science lab technicians has been alleviated by the introduction of a new user-friendly and cost-effective cell counter instrument.

The Olympus Corporation (Tokyo, Japan) portable Cell Counter model R1 was engineered with leading-edge liquid lens autofocus technology. More...
This technology mimics the performance of the human eye and is able to differentiate between living and dead cells and between single cells and cell clusters. Capitalizing on this technology, the user can adjust the minimum and maximum cell size so that only the desired cells are detected.

The instrument, which uses disposable slides with two chambers so that each slide can be used to make two separate cell counts, boasts a seven inch touch screen with intuitive interface, and is power by a sophisticated software package. The program is easily optimized and features cell size and roundness-based sorting capabilities, the ability to identify live and dead cells, clumped cell declustering, and automatic dilution calculator. Counts can be displayed as a histogram for analyzing certain size cells based on size distribution.

The R1 is able to store up to 1,000 counts and 300 different cell protocols for quick set-up and counting for routine culturing procedures. Result reporting is straightforward, and results are saved as CSV (Comma Separated Value) files that can be exported using a portable USB "disk-on-key" drive.

The R1 weighs only 2.1 kilograms and is small enough to fit into almost any workspace. The handle on the top of the counter makes it easy to transport, and a storage space for the AC adapter is conveniently built into the back of the counter.

Related Links:

Olympus Corporation



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.